Neurescue has developed an innovative medical device designed to address the critical challenges associated with cardiac arrest treatment. The NEURESCUE device is the first intelligent fluoroscopy-free balloon catheter that facilitates temporary aortic occlusion, which significantly enhances blood flow to the brain and heart during emergencies. By inflating a balloon in the descending aorta through a femoral artery introducer sheath, the device can rapidly redirect blood flow, increasing the chances of immediate resuscitation. This technology is particularly beneficial in emergency settings, as it allows for a quick response and can be utilized both in-hospital and out-of-hospital, bridging patients to advanced treatments such as ECMO, stents, or pacemakers.

The NEURESCUE device is characterized by its automated inflation and deflation features, which ensure a secure and effective occlusion without the need for estimation or second-guessing. It incorporates a pressure-limited filling system that protects against over-inflation and unintended pressure, enhancing safety during use. Designed specifically for emergency situations, the device's simple and portable design minimizes the number of user steps required for successful deployment, making it a vital tool in the fight against cardiac arrest, where traditional CPR methods often fall short in restoring adequate blood flow.

Denmark

Neurescue is a medical device startup pioneering an improved treatment of cardiovascular emergencies. The company has been awarded several innovation awards and large grants.

Neurescue

Company Details